Goldenwell Biotech Valuation

Is GWLL undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

Below Fair Value
Significantly Below Fair Value
Price-To-Book vs Peers
Price-To-Book vs Industry
Price-To-Book vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of GWLL when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate GWLL's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate GWLL's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for GWLL?

Key metric: As GWLL barely has revenue we use its Price-To-Book Ratio for relative valuation analysis.

The above table shows the Price to Book ratio for GWLL. This is calculated by dividing GWLL's market cap by their current book value.
What is GWLL's PB Ratio?
PB Ratio	5175.1x
Book	US$3.83k
Market Cap	US$19.80m

GWLL key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	21058.9x
Enterprise Value/EBITDA	n/a
PEG Ratio	n/a

Price to Book Ratio vs Peers

How does GWLL's PB Ratio compare to its peers?

The above table shows the PB ratio for GWLL vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PB	Estimated Growth	Market Cap
Peer Average	19.6x
MTEX Mannatech	1.6x	n/a	US$15.8m
DQWS DSwiss	76.2x	n/a	US$15.1m
NAII Natural Alternatives International	0.3x	n/a	US$27.4m
INBP Integrated BioPharma	0.5x	n/a	US$10.2m
GWLL Goldenwell Biotech	5175.1x	n/a	US$19.8m

Price-To-Book vs Peers: GWLL is expensive based on its Price-To-Book Ratio (5175.1x) compared to the peer average (5.3x).

Price to Book Ratio vs Industry

How does GWLL's PB Ratio compare vs other companies in the US Personal Products Industry?

10 Companies	Price / Book	Estimated Growth	Market Cap
NAII Natural Alternatives International	0.3x	n/a	US$27.40m
GRAM.F TPCO Holding	0.1x	n/a	US$19.07m
LIFD LFTD Partners	0.2x	n/a	US$8.32m
UPXI Upexi	0.2x	71.0%	US$4.60m

10 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Book vs Industry: GWLL is expensive based on its Price-To-Book Ratio (5175.1x) compared to the US Personal Products industry average (2.6x).

Price to Book Ratio vs Fair Ratio

What is GWLL's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

GWLL PB Ratio vs Fair Ratio.
Fair Ratio
Current PB Ratio	5175.1x
Fair PB Ratio	n/a

Price-To-Book vs Fair Ratio: Insufficient data to calculate GWLL's Price-To-Book Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Beauty Health

US$184.9m

Designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide.

SKIN

US$1.39

-22.3%

-37.5%

Kimberly-Clark de México S. A. B. de C. V

Mex$86.0b

Manufactures, distributes, and sells disposable products in Mexico.

KCDM.F

Mex$1.37

-5.8%

n/a

Reynolds Consumer Products

US$5.8b

Produces and sells products in cooking, waste and storage, and tableware product categories in the United States and internationally.

REYN

US$27.61

-0.5%

6.2%